Combining 5‐azacitidine with the E‐selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia
Article in British Journal of Haematology (April 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in British Journal of Haematology (April 2024)
Article in Nanoscale (March 2024)
Article in Frontiers in Oncology (October 2023)